johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Business Insider · 9h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

Zacks.com on MSN · 8h

Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.

Bears to hire Ben Johnson

USA Today · 2d

Detroit Lions fans crush Ben Johnson for leaving to Chicago Bears: 'Benedict Johnson'

Some Detroit Lions fans are beside themselves that Ben Johnson is staying in the NFC North with the Chicago Bears: 'Benedict Johnson'

The Washington Post · 1d

Ben Johnson agrees to become Bears head coach

Detroit Lions offensive coordinator Ben Johnson has agreed to become the Chicago Bears head coach, a person familiar with the situation told The Associated Press Ben Johnson helped Jared Goff establish himself as one of the NFL’s top quarterbacks.

Bleacher Report · 2h

Ben Johnson Hypes Caleb Williams, 'Loaded' Bears Roster After Leaving Lions

The Chicago Bears officially introduced Ben Johnson as their new head coach during a press conference on Wednesday, and the former Detroit Lions

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

1don MSN

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

4hon MSN

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

MassDevice8h

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

2don MSN

What Analysts Think of Johnson & Johnson Stock Ahead of Earnings

Johnson & Johnson is set to report earnings before the bell Wednesday, with analysts expecting revenue and profit growth from ...

Johnson & Johnson Q4 Preview: Can Earnings Bring Health Care 'Back To Life'?

Johnson & Johnson is one of several Dow Jones Industrial Average stocks reporting financial results this week. A look at the ...

TipRanks on MSN3d

Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards

Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Johnson & Johnson Q4 Profit Decreases

Bears to hire Ben Johnson

Related topics